News from Freeline
Charlotte2023-04-07T16:08:54+02:00Freeline has made the difficult decision to not progress our Fabry disease program further
Freeline has made the difficult decision to not progress our Fabry disease program further
April is Fabry Awareness Month! Join FIN in celebrating the #FabryHeroes!
Orphanet Journal of Rare Diseases recently published an in-depth history of the Sanofi Rare Disease Registries.
It is with great sadness that we learned of the passing of BongKi Lim, Fabry Korea's chairman for the past 22 years.
Evaluating the direct and indirect costs of Fabry disease
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for Pegunigalsidase Alfa for Treatment of Fabry Disease.
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for Pegunigalsidase Alfa for Treatment of Fabry Disease.
Join us for the Fabry Highlights from the Worldsymposium 2023 webinar with Dr Hopkin April 5th, 2023 at 6.30pm-7.30pm CET
April 1st is International Fabry Women’s Day! Join us in celebrating this special day.
Interview with Julia Alton from the Canadian Fabry Association When did you join your national patient association? I was 18 years old when I joined the Canadian Fabry Association (CFA) as a youth representative. What was the reason for joining? At the time I recognized the need for reaching the Fabry [...]